Moderna | MRNA - Cost Of Sales



Moderna reported $119M in Cost of Sales for its fiscal quarter ending in June of 2025.


Cost Of Sales Change Date
Acadia Pharmaceuticals USD 20.73M 342K Jun/2025
Adcock Ingram Holdings ZAR 3.18B 115.21M Dec/2024
Agios Pharmaceuticals USD 1.7M 617K Jun/2025
Alnylam Pharmaceuticals USD 142.95M 71.91M Jun/2025
Amgen USD 3.01B 406M Jun/2025
Biogen USD 605M 24.3M Jun/2025
BioMarin Pharmaceutical USD 154.94M 3.38M Jun/2025
Celltrion KRW 399.04B 120.81B Mar/2025
Cspc Pharmaceutical CNY 2.31B 299.94M Mar/2025
Divis Laboratories Ltd 10.68B 870M Jun/2025
Gilead Sciences USD 1.5B 39M Jun/2025
GlaxoSmithKline GBP 2.16B 241M Jun/2025
Incyte USD 78.77M 10.96M Jun/2025
Ionis Pharmaceuticals USD 4.15M 3.15M Jun/2025
Kangmei Pharma CNY 1.03B 35.75M Jun/2025
Knight Therapeutics CAD 47.25M 990K Sep/2024
Laboratorios Farma EUR 54.41M 97.64M Jun/2025
Malin Corporation EUR 15.4M 0 Dec/2020
Moderna USD 119M 29M Jun/2025
Organigram Holdings CAD 44.65M 2.96M Jun/2025
Pharma Mar EUR 2.78M 620K Jun/2025
Qiagen NV USD 199.25M 24.48M Jun/2025
Regeneron Pharmaceuticals USD 530.2M 264.7M Jun/2025
Sarepta Therapeutics USD 153.22M 15.66M Jun/2025
Sartorius EUR 468.1M 16.1M Jun/2025
Sino Biopharmaceutical CNY 2.49B 353.34M Dec/2024
Tilray USD 149.73M 9.39M Nov/2024
Ultragenyx Pharmaceutical USD 23M 5.66M Jun/2025
United Therapeutics USD 175.2M 102.3M Jun/2025
Vertex Pharmaceuticals USD 407.5M 44.5M Jun/2025
Zz Pientze Pharmaceu 1.94B 214.76M Jun/2025